Live Feeds
Press Releases
Insider Trading
FDA Approvals
Analyst Ratings
Insider Trading
SEC filings
Market insights
Analyst Ratings
Alerts
Subscriptions
Settings
RSS Feeds
Live Feeds
Press Releases
Insider Trading
FDA Approvals
Analyst Ratings
Insider Trading
SEC filings
Market insights
Analyst Ratings
Alerts
Subscriptions
Settings
RSS Feeds
Publish
Dashboard
Subscribe to $CTNM
Contineum Therapeutics Inc.
Subscribe to $CTNM
$CTNM
Biotechnology: Pharmaceutical Preparations
Health Care
IPO Year: 2024
Exchange: NASDAQ
Recent Analyst Ratings for Contineum Therapeutics Inc.
Date
Price Target
Rating
Analyst
10/22/2024
$32.00
Outperform
Robert W. Baird
See more ratings
